Am. J. Respir. Crit. Care Med., Volume 163, Number 2, February 2001, 335-338

Outcomes of Intensive Care Unit Care in Adults with Cystic Fibrosis

NAMITA SOOD, LINDA J. PARADOWSKI, and JAMES R. YANKASKAS

Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Cystic fibrosis (CF) causes progressive respiratory failure and death in more than 90% of patients. Mechanical ventilation has been discouraged in CF because of poor outcomes, but improved survival and the availability of lung transplantation have increased the indications for care of CF patients in the intensive care unit (ICU). We studied the outcomes of all CF patients admitted to the University of North Carolina Hospitals Medical ICU from January 1990 through December 1998. Seventy-six patients, ranging in ages from 17 to 45 yr (mean: 27 yr), and of whom 53% were female, had 136 admissions for exacerbations of CF with respiratory failure (RF, n = 65), hemoptysis (n = 33), antibiotic desensitization (n = 30), pneumothorax (n = 3), or other reasons (n = 5). Eighty-six percent of the patients with hemoptysis and all of those with desensitization and pneumothorax were alive 1 yr after ICU discharge. Of the 42 patients with RF, 37 (88%) required assisted ventilation. Twenty-three (55%) of the patients with RF survived to ICU discharge and 19 (45%) died. Seventeen (40%) of the patients with RF received lung transplants and 14 were alive 1 yr later. Without transplantation, three (7%) of the patients with RF were alive and three (7%) were dead 1 yr later. Sex, body mass index, and respiratory bacteria did not correlate with survival. We conclude that ICU care for adults with CF who have reversible complications is appropriate and effective. Ventilatory support is appropriate for some transplant candidates.

This article has been cited by other articles:

				P. G Noone Non-invasive ventilation for the treatment of hypercapnic respiratory failure in cystic fibrosis Thorax, January 1, 2008; 63(1): 5 - 7. [Full Text] [PDF]

				C. H Goss and J. L Burns Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis Thorax, April 1, 2007; 62(4): 360 - 367. [Abstract] [Full Text] [PDF]

				F. Petak, W. Habre, B. Babik, J. Tolnai, and Z. Hantos Crackle-sound recording to monitor airway closure and recruitment in ventilated pigs. Eur. Respir. J., April 1, 2006; 27(4): 808 - 816. [Abstract] [Full Text] [PDF]

				Spoken sessions Thorax, December 1, 2005; 60(suppl_2): ii4 - ii52. [Full Text] [PDF]

				T. G. Liou, F. R. Adler, and D. Huang Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1053 - 1059. [Abstract] [Full Text] [PDF]

				M. Ellaffi, C. Vinsonneau, J. Coste, D. Hubert, P.-R. Burgel, J.-F. Dhainaut, and D. Dusser One-year Outcome after Severe Pulmonary Exacerbation in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 158 - 164. [Abstract] [Full Text] [PDF]

				M. Dupont, A. Gacouin, H. Lena, S. Lavoue, G. Brinchault, P. Delaval, and R. Thomas Survival of Patients With Bronchiectasis After the First ICU Stay for Respiratory Failure Chest, May 1, 2004; 125(5): 1815 - 1820. [Abstract] [Full Text] [PDF]

				A.R. Glanville and M. Estenne Indications, patient selection and timing of referral for lung transplantation Eur. Respir. J., November 1, 2003; 22(5): 845 - 852. [Abstract] [Full Text] [PDF]

				R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF]

				K. Wallick, J. A. Nick, and D. M. Rodman Cystic Fibrosis Critical Care . No Longer an Oxymoron Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 310 - 312. [Full Text]